Fidelity Investments
NXL icon

Fidelity Investments’s Nexalin Technology NXL Stock Holding History

Fidelity Investments’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50
Closed -$522 – 5681
2026
Q1 		$522 Sell
50
-1,004
-95% -$15.7K ﹤0.01% 5159
2025
Q4 		$17.6K Buy
1,054
+1,007
+2,143% +$33.9K ﹤0.01% 4518
2025
Q3 		$1.28K Buy
47
+44
+1,467% +$1.25K ﹤0.01% 4990
2025
Q2 		$102 Buy
+3
New +$126 ﹤0.01% 5135

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments's NXL Position: Q2 2026 in Review

Fidelity Investments sold out of Nexalin Technology (NXL) in Q2 2026, closing a stake of 50 shares — an estimated $522 sold.

Fidelity Investments first reported a position in NXL in Q2 2025 and held it in 4 quarters. The position peaked at $17.6K in Q4 2025. 20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Fidelity Investments reported no remaining Nexalin Technology position as of Q2 2026 after selling out during the quarter.
  • Fidelity Investments sold 50 Nexalin Technology shares in Q2 2026, an estimated $522.
  • Fidelity Investments first reported a position in Nexalin Technology in Q2 2025 and held it in 4 quarters.
  • Fidelity Investments's Nexalin Technology position peaked at $17.6K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.